ChromaDex Corporation has announced the appointment of Ozan Pamir as the company's Chief Financial Officer and Principal Accounting Officer, effective October 21, 2024. Pamir will be succeeding James Lee, who is currently the Interim Chief Financial Officer and will continue as Controller after the transition. Pamir was the Chief Financial Officer at 180 Life Sciences Corp. and has previously worked at Ventum Financial Corp. He holds a B.A in Economics from McGill University. His compensation includes an annual salary of $400,000, a discretionary target bonus of 50% of his base salary, and he will participate in the company benefit plans similar to other senior executives. On October 21, 2024, Pamir will be granted an option to purchase shares of the company's common stock, with vesting conditions. If terminated without cause, Pamir will receive nine months’ base salary continuation. The company also issued a press release on September 20, 2024, about Pamir's hiring.
List of proper names: - ChromaDex Corporation - Ozan Pamir - James Lee - 180 Life Sciences Corp. - Ventum Financial Corp. - McGill University - Robert Fried